SHR-4602

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for SHR-4602, covering 2024-06-21 to 2025-01-07. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of SHR-4602 Infusion in Patients With SHR-4602 in Subjects With HER2-expressing or HER2-mutated Locally Advanced or Metastatic Solid Tumors [Phase 1]

See pricing